Sigilon Therapeutics Company

Sigilon is a biotech company which specializes in creating immune privileged products for unmet clinical needs.
Industry: P4 Medicine
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 1/1/2015
Employees Number: 51-100
Funding Status: IPO
Investors Number: 5
Total Funding: 263200000
Estimated Revenue: $10M to $50M
Last Funding Date: 2020
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership